Structure Therapeutics Inc. (GPCR)
NASDAQ·Healthcare·Biotechnology
$43.28
-4.52%
Mkt Cap $3.25B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $7.14M | — | — | -$0.35 | -$0.49 | -40.00% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.36 | -$0.37 | -2.78% | — | — |
| Q3 2025 Aug 6, 2025 | — | — | — | -$0.28 | -$0.36 | -28.57% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.24 | -$0.27 | -12.50% | — | — |
| Q1 2025 Feb 27, 2025 | — | $1.78M | — | -$0.23 | -$0.22 | +4.35% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.19 | -$0.20 | -5.26% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.23 | -$0.18 | +21.74% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.21 | -$0.19 | +9.52% | — | — |
| Q1 2024 Mar 8, 2024 | — | $1.33M | — | -$0.21 | -$0.17 | +19.05% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.29 | -$0.62 | -113.79% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.28 | -$0.60 | -114.29% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.41 | -$0.25 | +39.02% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.82 | -$1.14 | -39.02% | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.12 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.13 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.12 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.00 | — | — | — |